ARTICLE | Clinical News
TG1050: Phase I/Ib ongoing
August 1, 2016 7:00 AM UTC
Transgene said a safety review committee recommended continuation of a double-blind, placebo-controlled, international Phase I/Ib trial evaluating single injections and 3 once-weekly injections of TG1...